The Net Benefit of a treatment should take the correlation between benefits and harms into account
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Net Benefit of a treatment should take the correlation between benefits and harms into account
Authors
Keywords
Generalized pairwise comparisons, Prioritized outcomes, Benefit/harm, Net Benefit
Journal
JOURNAL OF CLINICAL EPIDEMIOLOGY
Volume 137, Issue -, Pages 148-158
Publisher
Elsevier BV
Online
2021-03-25
DOI
10.1016/j.jclinepi.2021.03.018
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Benefit-Risk Balance of Nab-Paclitaxel in Metastatic Pancreatic Adenocarcinoma
- (2019) Julien Péron et al. PANCREAS
- Open science: The open clinical trials data journey
- (2019) Frank Rockhold et al. Clinical Trials
- Clinical Trial Data Sharing: The Time Is Now
- (2019) Josephine P. Briggs et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Three Versus 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for Patients With Stage III Colon Cancer: Disease-Free Survival Results From a Randomized, Open-Label, International Duration Evaluation of Adjuvant (IDEA) France, Phase III Trial
- (2018) Thierry André et al. JOURNAL OF CLINICAL ONCOLOGY
- Duration of Adjuvant Chemotherapy for Stage III Colon Cancer
- (2018) Axel Grothey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Skin problems and EGFR-tyrosine kinase inhibitor
- (2016) Toshiyuki Kozuki JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- An assessment of the benefit-risk balance of FOLFIRINOX in metastatic pancreatic adenocarcinoma
- (2016) Julien Péron et al. Oncotarget
- Using Outcomes to Analyze Patients Rather than Patients to Analyze Outcomes: A Step Toward Pragmatism in Benefit:Risk Evaluation
- (2016) Scott R. Evans et al. Statistics in Biopharmaceutical Research
- The Net Chance of a Longer Survival as a Patient-Oriented Measure of Treatment Benefit in Randomized Clinical Trials
- (2016) Julien Péron et al. JAMA Oncology
- Assessing the benefit–risk of new treatments using generalised pairwise comparisons: the case of erlotinib in pancreatic cancer
- (2015) J Péron et al. BRITISH JOURNAL OF CANCER
- Afatinib versus cisplatin plus pemetrexed in Japanese patients with advanced non-small cell lung cancer harboring activatingEGFRmutations: Subgroup analysis of LUX-Lung 3
- (2015) Terufumi Kato et al. CANCER SCIENCE
- Correlation of cetuximab-induced skin rash and outcomes of solid tumor patients treated with cetuximab: A systematic review and meta-analysis
- (2015) Omar Abdel-Rahman et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Patient preference and decision-making for initiating metastatic colorectal cancer medical treatment
- (2015) Alex Z. Fu et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Treatment selections using risk-benefit profiles based on data from comparative randomized clinical trials with multiple endpoints
- (2014) B. Claggett et al. BIOSTATISTICS
- Review and Meta-Analysis of Incidence and Clinical Predictors of Anthracycline Cardiotoxicity
- (2013) Marzia Lotrionte et al. AMERICAN JOURNAL OF CARDIOLOGY
- Skin Rash could Predict the Response to EGFR Tyrosine Kinase Inhibitor and the Prognosis for Patients with Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
- (2013) Hong-bing Liu et al. PLoS One
- Benefits and harms of roflumilast in moderate to severe COPD
- (2013) Tsung Yu et al. THORAX
- A framework for organizing and selecting quantitative approaches for benefit-harm assessment
- (2012) Milo A Puhan et al. BMC Medical Research Methodology
- Analysis of randomized comparative clinical trial data for personalized treatment selections
- (2010) T. Cai et al. BIOSTATISTICS
- A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
- (2010) Ludwig Kappos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prediction of irinotecan and 5-fluorouracil toxicity and response in patients with advanced colorectal cancer
- (2010) B Glimelius et al. PHARMACOGENOMICS JOURNAL
- Generalized pairwise comparisons of prioritized outcomes in the two-sample problem
- (2010) Marc Buyse STATISTICS IN MEDICINE
- A first step to assess harm and benefit in clinical trials in one scale
- (2009) Maarten Boers et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started